Webinar: Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

Uncover the forces driving change in global pricing and access

In this expert-led discussion we explored the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).

At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this webinar, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry.

Ben Spurr (Head of Partnerships, Petauri Evidence) hosts the panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies.

The webinar recording will be released shortly. For more information email evidence@petauri.com. 

Our panel discuss:

• The global trends shaping pricing and market access strategy in 2025 and beyond
• How to build a global pricing strategy that supports successful launches in key markets
• Adapting to diverse health technology assessment (HTA) methodologies and payer value frameworks across Europe, Canada, and beyond
• The role of early payer engagement in shaping access and value
• Challenges and opportunities in pricing innovative therapies
• The significance of external reference pricing (ERP) and price erosion risks
• What is possible with innovative agreements and value-based pricing

Whether you’re preparing for a global launch, refining your pricing strategy, or navigating complex payer environments, this webinar offers practical insights and expert perspectives to support your success.